Trends in Use of Implantable Cardioverter-Defibrillator Therapy Among Patients Hospitalized for Heart Failure
Author(s) -
Sana M. AlKhatib,
Anne S. Hellkamp,
Adrian F. Hernandez,
Gregg C. Fonarow,
Kevin L. Thomas,
Hussein R. AlKhalidi,
Paul A. Heidenreich,
Stephen C. Hammill,
Clyde W. Yancy,
Eric D. Peterson
Publication year - 2012
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.111.066605
Subject(s) - medicine , implantable cardioverter defibrillator , heart failure , cardiology , intensive care medicine
Prior studies have demonstrated low use of implantable cardioverter defibrillators (ICDs) as primary prevention, particularly among women and blacks. The degree to which the overall use of ICD therapy and disparities in use have changed is unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom